CMS Issues Final Rule on FFY 2022 Hospice Payment Rates
The Centers for Medicare & Medicaid Services (CMS) has issued a final rule updating payments to hospice facilities for federal fiscal year (FFY) 2022.
The Centers for Medicare & Medicaid Services (CMS) has issued a final rule updating payments to hospice facilities for federal fiscal year (FFY) 2022.
The Centers for Medicare & Medicaid Services (CMS) has issued the federal fiscal year (FFY) 2022 inpatient rehabilitation facility (IRF) prospective payment system final rule updating payment policies and rates. The final rule is effective Oct. 1.
As previously shared in CHA News,the Department of Health Care Services (DHCS) distributed the invoices last week for the 2019-21 Hospital Fee Program Managed Care Directed Payment invoices for the July-December 2019 period.
CHA DataSuite has released two hospital-specific analyses of the calendar year (CY) 2022 Medicare home health prospective payment system (PPS) proposed rule and value-based purchasing (VBP) program.
In order to implement the state public health officer order released July 26, your hospital or health system may need to add additional testing for unvaccinated or incompletely vaccinated workers. There are several resources available through the State of California if you need to create additional testing capacity.
Upon the announcement of a state public health order on testing for employees in health care settings, the Department of Managed Health Care released All Plan Letter 21-020.
The California Department of Public Health (CDPH) has issued All Facilities letter (AFL) 21-26 for providers, including skilled-nursing facilities, on the requirement to report abuse, neglect, exploitation, and/or mistreatment of residents, particularly elders or dependent adults.
The U.S. Senate took the first step toward passing bipartisan infrastructure legislation on July 28 with a procedural vote of 67-32.
The Federal Emergency Management Agency (FEMA) has issued an advisory on reimbursable expenses for communications and outreach on the availability, safety, and efficacy of COVID-19 vaccinations.